The AZEK Company Inc. Profile Avatar - Palmy Investing

The AZEK Company Inc.

The AZEK Company Inc. engages in designing, manufacturing, and selling building products for residential, commercial, and industrial markets in the United States. It operates through two segments: Residential and Commercial.

Construction
US, Chicago [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q1 Q2 Δ in %
EV/EBITDA -41.13 71.46 121.39
Graham Fair Price 43.63 8.55 5.95
PEG -73.42 0.36 -1.35
Price/Book 24.58 5.16 4.14
Price/Cash Flow -26.98 -210.61 -165.86
Prices/Earnings -35.76 35.98 56.01
Price/Sales -26.95 17.12 23.43
Price/FCF -26.98 -210.61 -165.86
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q1 Q2 Δ in %
Gross Profit Margin -1.28 0.38 0.38
Operating Margin 255.90 0.18 0.05
ROA 97.28 0.02 0.01
ROE 0.02 0.04 93.92
ROIC < 0.005 0.03 709.50
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q1 Q2 Δ in %
Debt QOQ < 0.005 0.16 -97.57
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.81 5.19 537.42
EPS QOQ -0.41 1.00 141.67
FCF QOQ -1.35 < 0.005 99.92
Revenue QOQ -0.38 0.74 93.96
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q1 Q2 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 157.98 73.60 -53.41
Days Sales Outstanding (DSO) 12.13 28.90 138.35
Inventory Turnover 0.57 1.22 114.65
Debt/Capitalization 0.33 0.30 -10.51
Quick Ratio 1.55 2.01 29.85
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q1 Q2 Δ in %
Book Value 9.23 9.52 3.14
Cash 1.87 1.56 -16.34
Capex -0.12 -0.13 -9.76
Free Cash Flow -0.23 -0.23 -1.19
Revenue 1.63 2.87 75.91
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q1 Q2 Δ in %
Current Ratio 2.99 3.40 13.71
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 8.18 4.24 -48.16
Naive Interpretation Member
06 - Financial Health · Bad
End of AZEK's Analysis
CIK: 1782754 CUSIP: 05478C105 ISIN: US05478C1053 LEI: - UEI: -
Secondary Listings
AZEK has no secondary listings inside our databases.